Adicet Bio Inc reports results for the quarter ended in September 30 - Earnings Summary

ADICET Bio

07/11/2024 04:07

* Adicet Bio Inc  ACET.OQ  reported a quarterly adjusted
loss
of 34 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of $-1.16.  The mean expectation of eight analysts
for the quarter was for a loss of 34 cents per share. Wall
Street expected results to range from -37 cents to -29 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Adicet Bio Inc's reported EPS for the quarter was a loss
of 34
cents​.
    * The company reported a quarterly loss of $30.48 million.
    * Adicet Bio Inc shares had fallen by 9.0% this quarter and
lost 30.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 7.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Adicet Bio Inc is
7.00 
This summary was machine generated from LSEG data November 7 at
04:07 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.34          -0.34          Met
 Jun. 30 2024      -0.36          -0.33          Beat
 Mar. 31 2024      -0.39          -0.35          Beat
 Dec. 31 2023      -0.69          -0.69          Met